Xenetic Biosciences Inc.

NASDAQ: XBIO · Real-Time Price · USD
2.92
-0.07 (-2.34%)
At close: Aug 14, 2025, 3:55 PM
2.81
-3.93%
Pre-market: Aug 15, 2025, 07:58 AM EDT

Xenetic Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-3.96M -4.13M -6.55M -5.65M
Depreciation & Amortization
n/a n/a 27.04K 35.48K
Stock-Based Compensation
171.81K 283.08K 511.48K 410.44K
Other Working Capital
886.3K 845.00 -78.74K 4.06K
Other Non-Cash Items
n/a n/a 1.79M 24.27K
Deferred Income Tax
n/a n/a n/a -24.27K
Change in Working Capital
970.98K -263K -426.69K 461.19K
Operating Cash Flow
-2.82M -4.11M -4.65M -4.74M
Capital Expenditures
n/a n/a -500K n/a
Cash Acquisitions
n/a n/a -500K n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 500K n/a
Investing Cash Flow
n/a n/a -500K n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a 1.29M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 3.68K
Financial Cash Flow
n/a n/a n/a 11.45M
Net Cash Flow
-2.82M -4.11M -5.15M 6.72M
Free Cash Flow
-2.82M -4.11M -5.15M -4.74M